Epistatic connections between microphthalmia‐associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders

Waardenburg syndrome (WS) is an inherited sensorineural deafness condition in humans caused by melanocyte deficiencies in the inner ear and forelock. Mutation of microphthalmia‐associated transcription factor (MITF) is known to produce WS type IIA whereas mutations of either endothelin (EDN) or its receptor endothelin receptor B (EDNRB) produce WS type IV. However, a link between MITF haploinsuf‐ficiency and EDN signaling has not yet been established. Here we demonstrate mechanistic connections between EDN and MITF and their functional importance in melanocytes. Addition of EDN to cultured human melanocytes stimulated the phosphorylation of MITF in an EDNRB‐dependent manner, which was completely abolished by mitogen‐activated protein kinase kinase inhibition. The expression of melanocyte‐specific MITF mRNA transcripts was markedly augmented after incubation with EDN1 and was followed by increased expression of MITF protein. Up‐regulated expression of MITF was found to be mediated via both the mitogen‐activated protein kinase‐p90 ribo‐somal S6 kinase‐cAMP response element‐binding protein (CREB) and cAMP‐protein kinase A‐CREB pathways. In addition, EDNRB expression itself was seen to be dependent on MITF. The functional importance of these connections is illustrated by the ability of EDN to stimulate expression of melanocytic pigmentation and proliferation markers in an MITF‐dependent fashion. Collectively these data provide mechanistic and epi‐static links between MITF and EDN/EDNRB, critical melanocytic survival factors and WS genes. Sato‐Jin, K., Nishimura, E. K., Akasaka, E., Huber, W., Nakano, H., Miller, A., Du, J., Wu, M., Hanada, K., Sawamura, D., Fisher, D. E., Imokawa, G. Epistatic connections between microphthalmia‐associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders. FASEB J. 22, 1155–1168 (2008)

[1]  E. Keenan,et al.  The Microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. , 1995, Oncogene.

[2]  Murad Alam.  Fitzpatrick's Dermatology in General Medicine,6th ed , 2004 .

[3]  Y. Kurihara,et al.  Multiple roles for endothelin in melanocyte development: regulation of progenitor number and stimulation of differentiation. , 1996, Development.

[4]  A. Ferré-D’Amaré,et al.  Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences , 1994, Nature Genetics.

[5]  E. Price,et al.  α-Melanocyte-stimulating Hormone Signaling Regulates Expression of microphthalmia, a Gene Deficient in Waardenburg Syndrome* , 1998, The Journal of Biological Chemistry.

[6]  G. Imokawa,et al.  Intracellular Signaling Mechanisms Leading to Synergistic Effects of Endothelin-1 and Stem Cell Factor on Proliferation of Cultured Human Melanocytes , 2000, The Journal of Biological Chemistry.

[7]  D. Fisher,et al.  Microphthalmia Gene Product as a Signal Transducer in cAMP-Induced Differentiation of Melanocytes , 1998, The Journal of cell biology.

[8]  R. Delston,et al.  MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A , 2005, The Journal of cell biology.

[9]  S. Aaronson,et al.  Alkaptonuria: such a long journey , 1996, Nature Genetics.

[10]  S. Reed,et al.  Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. , 2000, Current opinion in cell biology.

[11]  E. Price,et al.  A Tissue-restricted cAMP Transcriptional Response , 2003, Journal of Biological Chemistry.

[12]  Andrew P. Read,et al.  Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene , 1994, Nature Genetics.

[13]  James A. Vaught,et al.  microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. , 1994, Genes & development.

[14]  G. Imokawa,et al.  Endothelins secreted from human keratinocytes are intrinsic mitogens for human melanocytes. , 1992, The Journal of biological chemistry.

[15]  Sridhar Ramaswamy,et al.  Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability , 2002, Cell.

[16]  R. Hammer,et al.  Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice , 1994, Cell.

[17]  R. Ballotti,et al.  Direct Regulation of the Microphthalmia Promoter by Sox10 Links Waardenburg-Shah Syndrome (WS4)-associated Hypopigmentation and Deafness to WS2* , 2000, The Journal of Biological Chemistry.

[18]  Masashi Yanagisawa,et al.  A missense mutation of the endothelin-B receptor gene in multigenic hirschsprung's disease , 1994, Cell.

[19]  Stephen L. Lessnick,et al.  β-Catenin–induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor , 2002, The Journal of Cell Biology.

[20]  E. Price,et al.  c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. , 2000, Genes & development.

[21]  T. Golub,et al.  Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. , 2004, Cancer cell.

[22]  R. Buscà,et al.  Different cis-Acting Elements Are Involved in the Regulation of TRP1 and TRP2 Promoter Activities by Cyclic AMP: Pivotal Role of M Boxes (GTCATGTGCT) and of Microphthalmia , 1998, Molecular and Cellular Biology.

[23]  R. Perlis,et al.  KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells. , 1993, Oncogene.

[24]  P. Sassone-Corsi,et al.  Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Carel Meijers,et al.  A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome) , 1996, Nature Genetics.

[26]  R. Halaban,et al.  Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes , 1988, The Journal of cell biology.

[27]  T. Brenn,et al.  Fitzpatrick’s Dermatology in General Medicine , 2007 .

[28]  S. Tilghman,et al.  The temporal requirement for endothelin receptor-B signalling during neural crest development , 1999, Nature.

[29]  K. Takeda,et al.  Epistatic relationship between Waardenburg Syndrome genes MITF and PAX3 , 1998, Nature Genetics.

[30]  K. Matsumoto,et al.  Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. , 1991, Biochemical and biophysical research communications.

[31]  G. Imokawa,et al.  The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis. , 1997, Pigment cell research.

[32]  S. Ramaswamy,et al.  MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. , 2003, The American journal of pathology.

[33]  C. Goding,et al.  Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator , 1994, Molecular and cellular biology.

[34]  A. Munnich,et al.  Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome) , 1996, Nature Genetics.

[35]  E. Price,et al.  MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes , 1998, Nature.

[36]  B. Kwon,et al.  The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function. , 1994, The Journal of biological chemistry.

[37]  G. Imokawa,et al.  Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes. , 1996, The Biochemical journal.

[38]  H. Suzuki,et al.  Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene. , 1996, Biochemical and biophysical research communications.

[39]  G. Imokawa,et al.  Endothelin-1 as a new melanogen: coordinated expression of its gene and the tyrosinase gene in UVB-exposed human epidermis. , 1995, The Journal of investigative dermatology.

[40]  W. Pavan,et al.  Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3 , 2000, Human Genetics.

[41]  Michael E. Greenberg,et al.  Coupling of the RAS-MAPK Pathway to Gene Activation by RSK2, a Growth Factor-Regulated CREB Kinase , 1996, Science.

[42]  G. Imokawa,et al.  Biological characterization of human fibroblast-derived mitogenic factors for human melanocytes. , 1998, The Biochemical journal.

[43]  G. Imokawa,et al.  Effects of endothelins on signal transduction and proliferation in human melanocytes. , 1991, The Journal of biological chemistry.

[44]  L. Larue,et al.  Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression , 2005, Nature.

[45]  W. Pavan,et al.  Piebald lethal (sl) acts early to disrupt the development of neural crest-derived melanocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  W. Silvers,et al.  Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases. , 1998, Cancer research.

[47]  D. Fisher,et al.  Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. , 2001, Molecular cell.

[48]  N. Jenkins,et al.  Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein , 1993, Cell.

[49]  X. Liu,et al.  A gene for Waardenburg Syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12–p14.1 , 1994, Nature Genetics.

[50]  R. Hammer,et al.  Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons , 1994, Cell.

[51]  K. Bille,et al.  Regulation of the Microphthalmia-associated Transcription Factor Gene by the Waardenburg Syndrome Type 4 Gene,SOX10 * , 2000, The Journal of Biological Chemistry.

[52]  B. Gilchrest,et al.  Human melanocyte growth and differentiation: a decade of new data. , 1991, The Journal of investigative dermatology.

[53]  H. Suzuki,et al.  Transcriptional activation of the melanocyte-specific genes by the human homolog of the mouse Microphthalmia protein. , 1995, Journal of biochemistry.

[54]  M. Wegner,et al.  Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. , 2000, Human molecular genetics.

[55]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[56]  S. Nishikawa,et al.  Distinct stages of melanocyte differentiation revealed by anlaysis of nonuniform pigmentation patterns. , 1996, Development.

[57]  R. Halaban,et al.  Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.